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ABSTRACT: Complete and transparent reporting of key elements of diagnostic accuracy studies
for infectious diseases in cultured and wild aquatic animals benefits end-users of these tests,
enabling the rational design of surveillance programs, the assessment of test results from clinical
cases and comparisons of diagnostic test performance. Based on deficiencies in the Standards for
Reporting of Diagnostic Accuracy (STARD) guidelines identified in a prior finfish study (Gardner
et al. 2014), we adapted the Standards for Reporting of Animal Diagnostic Accuracy Studies —
paratuberculosis (STRADAS-paraTB) checklist of 25 reporting items to increase their relevance to
finfish, amphibians, molluscs, and crustaceans and provided examples and explanations for each
item. The checklist, known as STRADAS-aquatic, was developed and refined by an expert group
of 14 transdisciplinary scientists with experience in test evaluation studies using field and experi-
mental samples, in operation of reference laboratories for aquatic animal pathogens, and in devel-
opment of international aquatic animal health policy. The main changes to the STRADAS-paraTB
checklist were to nomenclature related to the species, the addition of guidelines for experimental
challenge studies, and the designation of some items as relevant only to experimental studies and
ante-mortem tests. We believe that adoption of these guidelines will improve reporting of primary
studies of test accuracy for aquatic animal diseases and facilitate assessment of their fitness-for-
purpose. Given the importance of diagnostic tests to underpin the Sanitary and Phytosanitary
agreement of the World Trade Organization, the principles outlined in this paper should be
applied to other World Organisation for Animal Health (OIE)-relevant species.
KEY WORDS:  Reporting standards · Sensitivity · Specificity · Finfish · Amphibians · Molluscs ·
Crustaceans · STRADAS-paraTB · Diagnostic validation
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INTRODUCTION
Estimation of indices of test accuracy, such as diag-
nostic sensitivity and specificity, is an important com-
ponent of the evaluation process for tests used for
detection of infectious diseases in aquatic and terres-
trial animals. The World Organisation for Animal
Health (OIE) Manual of Diagnostic Tests for Aquatic
Animals 2015 (OIE 2015a) describes a 4-stage valida-
tion pathway to assess a test’s fitness-for-purpose: (1)
analytical characteristics, (2) diagnostic sensitivity
and specificity, (3) reproducibility among laborato-
ries, and (4) program implementation. Diagnostic
sensitivity and specificity estimates are considered
essential for appropriate interpretation of test results
for presumptive diagnosis, confirmation of clinical
disease, and targeted surveillance for disease free-
dom to support animal trade, to list a few purposes.
These parameters are important to consider when
comparing different tests for the same disease. The
OIE Aquatic Manual pertains to finfish, amphibians,
molluscs and crustaceans; however, some classes of
pathogens move between taxonomic groups, so the
principles outlined in this paper should be applied
more generally. For example, some ranaviruses (e.g.
Frog virus 3), which are listed by the OIE as a cause
of disease in amphibians, may also cause disease in
finfish and reptiles (Waltzek et al. 2014). The same
tests may be applied in species from all of these
groups even though the diagnostic characteristics
may be different.
Regardless of the study design chosen for estima-
tion of diagnostic sensitivity and specificity, many
health-related journals recommend application of
the Standards for Reporting of Diagnostic Accuracy
(STARD) statement (Bossuyt et al. 2003a,b) to en -
hance clear and transparent peer-reviewed reporting
of pertinent information from a study. First published
in 2013, STARD is based on recommendations of sci-
entists and editors and is now endorsed by more than
200 biomedical journals. STARD does not prescribe
design elements but has 25 checklist items that spec-
ify key information that should be reported. Because
of different purposes of testing in human and animal
health, STARD was modified for paratuberculosis in
ruminants to account for different terminology and
epidemiological units, and these guidelines were
named the Standards for Reporting of Animal Diag -
nostic Accuracy Studies — paratuberculosis (STRA -
DAS- paraTB) (Gardner et al. 2011). Recently, we
used the STARD checklist to evaluate the quality of
reporting in finfish studies and found highly variable
reporting of its 25 items, a lack of guidance for
researchers reporting use of experimental challenge
studies to obtain sensitivity and specificity estimates,
and 2 items that were minimally relevant to finfish
studies (Gardner et al. 2014).
The purpose of the present study was to modify the
STRADAS-paraTB guidelines, which was authored
by 2 of us (I.A.G. and R.J.W.), to increase its rele-
vance to test accuracy studies in aquatic animals (e.g.
finfish, amphibians, molluscs and crustaceans) and to
provide examples and explanations/elaborations for
each of the 25 checklist items. In a PubMed search in
October 2015, we did not find any published test ac -
curacy studies involving aquatic animals that explic-
itly mentioned or followed the STARD or STRADAS-
paraTB reporting recommendations. Reasons could
include lack of awareness of or perceived lack of rel-
evance of these guidelines. Therefore, our motivation
was that in creasing the relevance of these checklist
items for aquatic animals would ultimately enhance
adoption of reporting guidelines for test accuracy
studies in aquatic animals regardless of species.
METHODS AND PROCESSES
The initial checklist known as STRADAS-aquatic
was developed by 3 of us (Gardner, Caraguel, and
Whittington) and was subsequently expanded and
refined by the expert panel. Potential experts were
identified based on finfish papers reviewed in Gard-
ner et al. (2014) and on knowledge of test evaluation
papers in amphibians, molluscs, and crustaceans.
Inclusion criteria were that experts must have either
published a paper on test accuracy, were the head or
member of a European Union (EU) or OIE reference
laboratory for aquatic animal pathogens, or were
involved in formulation of policy regarding trade in
aquatic animals.
Of 11 additional experts contacted by one of us
(Gardner), all agreed to participate. Contributors
self-classified themselves as molecular biologists
(Pur cell), molecular virologists (Arzul, Corbeil, Gar -
ver, Moody, and Waltzek), aquatic animal health
 scientists/researchers or epidemiologists (Caraguel,
Crane, Gardner, Hick, Olesen and Whittington), or
laboratory diagnosticians (Warg). Of the 14 authors, 4
(Crane, Gardner, Purcell, and Waltzek) are associate
editors or editorial board members of journals pub-
lishing aquatic animal heath papers, 4 (Caraguel,
Garver, Olesen, and Purcell) authored a paper that
was evaluated by Gardner et al. (2014), and 5 others
(Crane, Hick, Moody, Waltzek and Whittington) had
authored a manuscript on test accuracy. Six (Arzul,
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Crane, Moody, Olesen, Purcell, and Whittington) are
heads or members of OIE or EU reference laborato-
ries for aquatic animal diseases, and one of us (Gal-
lardo Lagno) is a member of the OIE Aquatic Animal
Health Standards Commission. Collectively, authors
had experience with species in all 4 taxonomic
groups and with terrestrial animals.
Experts were required to contribute examples and
elaborations based on their own experiences and/or
knowledge of published literature and critically re -
view the manuscript including suggesting improved
wording in the examples used. The panel operated
remotely by email and telephone and as opportuni-
ties arose, the lead author had in-person discussions
with coauthors at conferences. No major discrepan-
cies in opinions as to content were evident during the
process although there was discussion as to the most
appropriate item for some considerations. During the
writing process, reference to design issues was mini-
mized to maintain focus on reporting.
THE STRADAS-aquatic CHECKLIST
Of the 25 STRADAS-paraTB checklist items, the
following adaptations were made: (1) substantial
changes to 5 items (Items 3, 4, 6, 23, and 25) to in -
corporate use of experimental challenge studies; (2)
modifications to 2 items (Items 17, 20) for ante-
mortem test application only and to a single item
(Item 14) for field study application only; (3) substitu-
tion of the word ‘herd’ or ‘flock’ with ‘population’ in
several items (Items 2, 3, 4, 11, 15, and 16); and (4)
minor wording changes to 10 items (Items 2, 5, 7, 10,
12, 13−16, and 19) (see bolded adaptations in
Table 1).
We present examples from published papers which
are intended to represent best practices, but in some
cases improvements are suggested. Although many
examples are from PCR evaluation studies, we
emphasize that the principles apply equally well to
traditionally used tests such as virus, bacterial, and
parasite isolation, to gross and histopathological
examination of organs and tissues, to tests that detect
serological responses and tests based on new tech-
nology such as in situ hybridisation using RNA
probes and multiplex assays using reagents conju-
gated to fluorescent beads.
As in Gardner et al. (2011), we use square brackets
for any wording additions that improve readability of
an example and for spelling out acronyms. We use
the term test under evaluation (TUE) to designate
any test for which diagnostic sensitivity and speci-
ficity are estimated. Definitions and terms used in the
manuscript are in the Supplement (www.int-res.com/
articles/suppl/d118p091_supp.pdf).
The structure of this manuscript reflects that of the
STARD checklist and a research article: Title/ Abstract/
Keywords; Introduction; Materials and  me thods; Re -
sults; and Discussion.
Title/Abstract/Keywords
Item 1: Identify the article as a study of diagnostic
accuracy (recommend MeSH [medical subject head-
ings] terms ‘sensitivity and specificity’).
Examples:
Kent et al. (2013) entitled their paper ‘Sensitivity
and Specificity of Histology for Diagnoses of Four
Common Pathogens and Detection of Nontarget
Pathogens in Adult Chinook Salmon (Oncorhynchus
tshawytscha) in Fresh Water’ and included estimates
of sensitivity and specificity in their abstract. In con-
trast, Garver et al. (2011, p. 95) did not include sensi-
tivity and specificity in their title but rather in their
abstract: ‘Test performance characteristics evaluated
on experimentally infected Atlantic salmon Salmo
salar L. revealed a diagnostic sensitivity (DSe) ≥ 93%
and specificity (DSp) = 100%.’ Both papers were
identified when diagnostic sensitivity and specificity
were used as search terms.
Explanation:
The MEDLINE/PubMed database uses a controlled
vocabulary thesaurus termed MeSH (www.nlm. nih.
gov/bsd/disted/meshtutorial/introduction) to allow
hierarchical searching of the biomedical literature
including diagnostic accuracy studies. Use of the
MeSH terms ‘sensitivity’ and ‘specificity’ is recom-
mended in the title, keywords or abstract to increase
the likelihood of retrieval of relevant studies in a bib-
liographic search. However, studies that use the
terms in their analytical rather than diagnostic con-
text may also be retrieved and require exclusion
because they lack estimates of diagnostic sensitivity
and specificity. The term ‘validation’, which is com-
monly used by OIE for test accuracy studies, has a
nearest match of ‘validation studies’ in MeSH. This
term describes works in which the reliability and rel-
evance of a procedure for a specific purpose are
established, and thus it is relevant to more than diag-
nostic sensitivity and specificity studies. Inclusion of
additional databases (e.g. CAB Abstracts, www. cabi.
org/publishing-products/online-information-resources/
cab-abstracts/) in the search may be needed to
retrieve all relevant articles because PubMed may
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Section and Item Description of item
topic
TITLE/ 1 Identify the article as a study of diagnostic accuracy (recommend MeSH [MeSH: medical subject 
ABSTRACT/ headings] heading ‘sensitivity and specificity’).
KEYWORDS
INTRODUCTION 2 State the intended purpose of the TUE and reasons for test accuracy assessment, such as
estimation of diagnostic accuracy or comparison of accuracy between tests in a specified matrix
(specimen type) for a defined purpose at the animal or population level.
MATERIALS 3a For field studies, describe the study population including other susceptible species around the 
AND METHODS target population. Describe setting and locations where data were collected for all relevant 
Animals and levels of the study sample (animals and populations), detailing inclusion and exclusion criteria.
populations 3b For experimental studies, describe source, life stage, and health history of aquatic animals and
specifically indicate prior infection status for the pathogen(s) of interest, including diagnostic
testing in study animals and/or source population.
4a For field studies, describe selection of animals and populations. Describe sample selection
methods (random, convenience, etc.) within each level of the sampling hierarchy (e.g. regions,
sites, cages/net-pens, tanks, or ponds), including exclusion criteria, and number of study
animals and populations.
4b For experimental studies, describe (1) design (e.g. number of treatment and control groups),
randomization process, numbers of replicates (number of housing units and animals per
housing unit), duration of experiment including start date, and challenge conditions (e.g.
challenge strain and passage level for the organism(s), dose, exposure route), and animal use
and care committee approval, (2) sampling (time post-challenge that samples were harvested
including numbers at each time), and (3) husbandry and environmental conditions (e.g.
housing type, acclimation time, water source and relevant physical and chemical characteris-
tics, feeding regimen, handling and care).
5 Describe specimen collection: Describe the collection, target organs including gross lesions (if
sampled), specimen size and number sampled, transportation, handling (laboratory scientist
and/or field collection) and storage (laboratory and/or field) methods and times for specimens
prior to the performance of the test under evaluation (TUE) and the reference standard.
6 Describe study design: For field studies, was data collection planned before the TUE and
reference standard were performed (prospective study) or after (retrospective study)? For
experimental studies, were archived samples included? Describe details of storage and
retrieval techniques and times.
Test methods 7 Describe the reference standard (if used) and its rationale.
8 Describe technical specifications of materials and methods involved including how and when
measurements were taken, and/or cite references for TUE and reference standards. Specify
quality control samples for TUE and reference standard and specimen/analytical unit size of
tested samples.
9 Describe the outcome measure and rationale for the cutoffs and/or categories of the results of the
TUE and reference standard.
10 Describe the name, location, and qualifications of the laboratory, including the number, training,
and expertise of persons executing the TUE and reference standard. Specifically indicate if the
laboratory or analyst(s) is involved in any internal or external assessment program (e.g.
proficiency testing).
11 Describe whether or not the readers of the TUE and reference standard were blind (masked) to
the results of the other test and describe any individual or population-level information available
to the readers.
Statistical 12 Describe methods for calculating and comparing measures of diagnostic accuracy, and the 
methods statistical methods used to quantify uncertainty in the estimates (e.g. 95% confidence or
probability intervals).
13 Describe methods for estimating test repeatability and reproducibility, if done.
RESULTS 14 For field studies, report when study was done, including start and end dates.
Animals and 15 Report demographic and other biologically relevant characteristics of the study sample at the 
populations individual level (e.g. age, sex, ploidy species, genotype if known, weight, and risk factors) and at
the population levels (e.g. production system, water quality, water temperature, and water
salinity).
Table 1. Standards for Reporting of Animal Diagnostic Accuracy Studies (STRADAS-aquatic) checklist of items for reporting
in diagnostic test accuracy studies for finfish, crustaceans, and molluscs based on the STARD (www.stard-statement.org) and
STRADAS paratuberculosis (STRADAS-paraTB) (Gardner et al. 2011) checklists. TUE: test under evaluation. Modification of 
text from the STRADAS-paraTB checklist is in bold
(Table continued on next page)
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include only a subset of aquatic animal journals pub-
lishing studies of diagnostic accuracy and other
aquatic topics. For example, Journal of Fish Pathol-
ogy and the Bulletin of European Association of Fish
Pathologists are not indexed in PubMed.
Introduction
Item 2: State the intended purpose of the TUE and
reasons for test accuracy assessment, such as estima-
tion of diagnostic accuracy or comparison of accuracy
between tests in a specified matrix (specimen type)
for a defined purpose at the animal or population
level.
Example:
The aim of our study was to develop molecular tools
for a specific, rapid and sensitive diagnostic of bona -
miosis in the European flat oyster Ostrea edulis … We
compared the sensitivity of these new diagnostic
assays [species-specific conventional PCR, real-time
PCR, and multiplex PCR] with 2 OIE listed procedures
(www.oie.int/international- standard-setting/aquatic-
manual/access-online/), viz, the standard histological
procedure and the PCR-RFLP assay, assuming that
none of the compared procedures could be consid-
ered as a ‘gold standard’ (Ramilo et al. 2013, p. 150).
In the introduction, the authors also indicate that
sensitive and specific methods are needed to carry
out early detection of Bonamia spp. with the aim of
preventing infection of healthy animals and disper-
sion of the agent to non-affected areas, implying that
was their study purpose.
Explanation:
The concept of ‘fitness for an intended purpose’ is
fundamental to the validation pathway recommended
in the OIE Manual of Diagnostic Tests for Aquatic
Animals 2015 (OIE 2015a), including evaluation in
the species for which the test is intended. Because
choice of study populations and animals will vary
with purpose, clear specification of the study aims
and an intended purpose is essential. The objective
statement by Ramilo et al. (2013) above could have
been improved by an explicit description of test pur-
pose and reference to specimen type, namely gills
and gonads, because sensitivity will vary with tissue
predilection and load of the target analyte. Ideally,
the objective statement should also specify the epi-
demiological unit(s) of interest because test results
for aquatic food animals are typically interpreted at a
population rather than at the individual animal level.
Applicable OIE-recognized purposes should also
be reported wherever possible. For example, in a
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Table 1 (continued)
Section and Item Description of item
topic
16 Report the number of animals and populations satisfying the inclusion criteria that did or did not
undergo the TUE and/or the reference standard; describe why animals and populations failed to
receive either test.
Test results 17 Report time interval between collection of samples for the TUE and the reference standard, and
interventions administered between for samples collected ante-mortem.
18 Report distribution of severity of disease or stage of infection (define criteria) and other relevant
diagnoses or treatments in animals in the study sample.
19 Report a cross tabulation of the results of the TUE (including indeterminate and missing results)
by the results of the reference standard. For continuous results, report the distribution of the test
results by the results of the reference standard.
20 Report any adverse events from performing the TUE or the reference standard for samples
collected ante-mortem.
Estimates 21 Report estimates of diagnostic accuracy and measures of statistical uncertainty (e.g. 95%
confidence intervals).
22 Report how indeterminate results, missing responses, and outlier values of the TUE and the
reference standard were handled.
23 Report estimates of variability of diagnostic accuracy between relevant subpopulations, opera-
tors/readers, host factors, agent factors, or testing sites, if done. For challenge studies, report
temporal variation in sensitivity estimates compared with days post-challenge.
24 Report estimates of test repeatability and reproducibility, if done.
DISCUSSION 25 Discuss the fitness for the stated purpose, and the utility of the TUE in various settings (clinical,
research, surveillance, etc.) in the context of the currently available tests. For challenge studies,
critically evaluate the relevance of the experimental challenge study to naturally occurring
infection/disease and explain why the latter source of samples was not used.
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study of the OIE-listed amphibian disease chytrid-
iomycosis (Batrachochytrium dendrobatidis), Hyatt et
al. (2007) evaluated the diagnostic accuracy, repeata-
bility and reproducibility of histopathology, histo-
chemistry, and real-time TaqMan PCR as well as var-
ious sampling protocols (toe clipping, water baths
and filters, and swabs). They stated that uses for
these assays and protocols, as per the quantification
results, are purposes ‘… analogous to those defined
by the OIE [5 specific functions listed in detail]…for
assays intended for the detection and for minimising
the translocation of pathogens via the international
movement of livestock and associated commodi-
ties …’ (Hyatt et al. 2007, p. 176)
Materials and methods
Animals and populations
Item 3a: For field studies, describe the study popu-
lation including other susceptible species around the
target population. Describe setting and locations
where data were collected for all relevant levels of
the study population (animals and populations),
detailing inclusion and exclusion criteria.
Example:
Three Atlantic salmon seawater sites were studied [on
the west coast of Norway]. Two sites were included at
the start of their PD [pancreas disease] outbreak (sites
1 and 2). A third site was included at the time of smolt
seawater transfer because of a high probability of
contracting PD based on its location in close proximity
to existing outbreaks (site 3). This third site was also
included in a cohort study, where the smolt groups
tested negative for SAV [salmonid alphavirus] in the
freshwater phase. All sites were situated in a region
considered endemic for PD although with no recent
history of clinical PD … Detailed site, stock and out-
break information [in cluding fallow period, time of
seawater transfer, number of fish on farm at seatrans-
fer, PD diagnosis, fish weight, cumulative PD-related
mortality, sampling period and time of last sample col-
lection] can be found in Table 1 … Each site had 3
cages selected for inclusion in the study, preferably
cages evenly distributed within the site and contain-
ing smolt from different smolt producers (Jansen et al.
2010, p. 725).
Explanation:
External generalizability of estimates of diagnostic
sensitivity and specificity to related species and other
geographically distinct populations is in part de -
pendent on the study design, sampling methods
(Item 4a), knowledge of management and housing
practices (wild stocks vs. cultured animals), concur-
rent diseases, and animal demographics in the sam-
pled and source populations. Relevant environmen-
tal parameters at study sites (e.g. temperature and
salinity) should be reported for field studies and for
tank experiments (see Item 4b). Disclosure of these
parameters as well as disease-specific variables
where available, such as pathogen load, tissue distri-
bution, and prevalence within the population, allow
for assessment of generalizability. Start and end
dates of the study should also be reported in the
‘Materials and methods’ or ‘Results’ sections of the
paper (see Item 14).
Item 3b: For experimental studies, describe source,
life stage, and health history of aquatic animals and
specifically indicate prior infection status for the
pathogen(s) of interest, including diagnostic testing
in study animals and/or source population.
Example:
Spawning fall Chinook salmon to provide SPF [specific-
pathogen-free] progeny for this research were ob -
tained from Strawberry Creek, Wisconsin in October
2004 … Five families were selected on the basis of
negative kidney tissue results by ELISA [screening]
testing [for Renibacterium salmoninarum], negative
or borderline positive ovarian fluid results by ELISA
testing, and negative or borderline positive ovarian
fluid results by MF-FAT [membrane filtration-fluores-
cent antibody technique] testing (≤1 bacteria in 150
microscopic fields). In November 2004, eyed eggs
from the selected families were transferred from Wild
Rose Hatchery, Wisconsin to the Western Fisheries
Research Center in Seattle, Washington. The fish
were hatched and reared in sand-filtered, UV-treated
Lake Washington water for 2 years prior to challenge.
(Elliott et al. 2013, p. 787)
Explanation:
Estimates of test performance in experimental
challenge studies may be influenced by prior infec-
tion history, concurrent disease and host genetics.
Consideration of prior exposure to pathogens is even
more important when the TUE specifically addresses
prior infection status (e.g. serological tests for anti-
bodies). Hence, the genetic background of the ani-
mals (selected or wild type), the health history of ani-
mals (e.g. recorded outbreaks in wild or farmed
source populations) that are used in experiments
should be reported, as should results of testing a sub-
sample of animals (e.g. by histology and PCR) to con-
firm freedom of infection by the agent under investi-
gation as in the preceding example.
Item 4a: For field studies, describe selection of ani-
mals and populations. Describe sample selection meth-
ods (random, convenience, etc.) within each level of
the sampling hierarchy (e.g. regions, sites, cages/
net-pens, tanks, or ponds), including exclusion crite-
ria and number of study animals and populations.
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Example:
Sample collection was conducted in September 2003.
Samples were taken from 3 BC Atlantic salmon farms
[shown in Fig. 1 in their paper] that represented dif-
ferent prevalence populations: (1) a farm undergoing
an IHNV [infectious hematopoietic necrosis virus]
epizootic (fish with high IHNV prevalence; average
weight = 1.7 kg), (2) a farm that had recently experi-
enced an epizootic (fish with low IHNV prevalence;
average weight = 5.0 kg), and (3) a farm that never
had experienced an outbreak (fish with no IHNV;
average weight = 1.5 kg). From farm 1, 50 fresh mor-
talities or moribund fish were sampled from 6 affected
cages via cage removal by a mortality diver and an
uplift system. From farm 2, 50 fish from 9 affected
cages were taken by the mortality diver. From farm 3,
50 healthy fish from 1 pen were seined at the IHNV-
negative site [see Table 2 in their paper] (McClure et
al. 2008, p. 13).
Explanation:
The method of sampling should be described in
sufficient detail to allow replication of the approach
in other studies and ensure consistency in sampling
from pen to pen, site to site etc., thereby allowing
readers to generalize results to other populations.
The example from McClure et al. (2008) indicates a
targeted approach in Farms 1 and 2 to obtain sam-
ples from clinically affected fish and a convenience
(non-random) sample of healthy fish at Farm 3 for
estimation of specificity.
Sampling of moribund and clinically affected ani-
mals that fit the case definition is essential to provide
positive controls as part of a test accuracy study.
Gross pathology, specific morbidity signs and histo -
pathological analysis of clinically affected animals
are required to obtain a diagnosis and should be re -
ported as pertaining to the purpose of testing. When
another pathogen-specific test is available (e.g. con-
ventional PCR), besides the test being validated, it
increases the likelihood of accurate diagnosis. Like-
wise, the same testing protocol should be performed
and reported for animals from disease-free areas that
were used as negative controls.
Item 4b: For experimental studies, describe (1) de -
sign (e.g. number of treatment and control groups),
randomization process, numbers of replicates (num-
ber of housing units and animals per housing unit),
duration of experiment including start date, and
challenge conditions (e.g. challenge strain and pas-
sage level for the organism(s), dose, exposure route),
and animal use and care committee approval, (2)
sampling (time post-challenge that samples were
harvested including numbers at each time), and (3)
husbandry and environmental conditions (e.g. hous-
ing type, acclimation time, water source and relevant
physical and chemical characteristics, feeding regi-
men, handling and care).
Examples:
Newly metamorphosed, lab-bred Ambystoma ti gri -
num nebulosum from 2 different clutches were
housed individually in plastic containers in 946 ml of
water before the experiment. Each was fed 2 crickets,
twice a week, and had its water changed weekly. Ani-
mals were randomly assigned to 2 groups: infected
and control. Each group included metamorphosed
animals from each clutch. A total of 68 animals, 34
from each clutch, were in the experimentally in fected
group, and 18 were in the uninfected control group.
At 5 times (2, 5, 8, 12, and 15 days), 14 in fected ani-
mals (7 from each clutch) and 4 uninfected control
animals (2 from each clutch) were sampled to assess
the diagnostic performance of the PCR test (Greer &
Collins 2007, p. 526–527).
To generate a population of VHSV [viral hemorrhagic
septicemia virus] infected fish, 63 Atlantic salmon
smolts (mean weight 223 g per fish) were i.p.
[intraperitoneally] injected with 1 × 104 pfu [plaque
forming units] fish−1 of VHSV isolate 99-292 (geno-
type IVa). For a population of non-infected fish,
50 Atlantic salmon were left unhandled and main-
tained in a separate tank. Fish were held in a 750 l
tank with 8°C seawater. At 3, 5, 7, 10, and 11 d post
challenge, 10 fish from each of the virus-challenged
and negative control tanks were killed with an over-
dose of tricaine methane sulphonate (MS_222)
(Garver et al. 2011, p. 102).
Explanation:
The nature of samples generated during experi-
mental infection will be different from samples
obtained during application of the TUE for field test-
ing. Husbandry under experimental conditions will
not be the same as in the wild or commercial aqua-
culture. Factors including stocking density, water
source and relevant physical and chemical character-
istics, stress levels, health status including concur-
rent infection, and quality and quantity of feed are
likely to influence the prevalence of infection and the
quantity of pathogen present. By describing the con-
ditions under which the experimental samples were
generated, differences in these factors which might
affect diagnostic characteristics of the test can be
accounted for. The challenge conditions, particularly
the dose and strain of pathogen, should be reported
to allow readers to evaluate how well the experimen-
tal model reflects natural exposure under field condi-
tions. The examples by Greer & Collins (2007) and
Garver et al. (2011) include most of the necessary
elements with the exception of Animal Ethics Com-
mittee approval of the experiment design. Research
studies with amphibians and fish, but typically not
molluscs and crustaceans, must be approved by the
Animal Ethics Committee in most research institu-
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tions and should be reported as done in Purcell et al.
(2013), with the possible addition of approved proto-
col numbers (see Hyatt et al. 2007).
Item 5: Describe specimen collection. Describe the
collection, target organs including gross lesions (if
sampled), specimen size and number sampled, trans-
portation, handling (laboratory scientist and/or field
collection) and storage (laboratory and/or field)
methods and times for specimens prior to the per-
formance of the test under evaluation (TUE) and the
reference standard.
Example:
From each of the 20 [euthanized] fish, heart and mid-
kidney tissue in RNAlater® (Ambion) for virological
examination by Rt RT-PCR [real-time reverse tran-
scriptase PCR] and heparinized blood samples for
detection of antibodies against SAV [salmonid alpha -
virus] were collected. Additionally, heart and mid-
kidney tissues were collected in viral transport me -
dium [Eagle’s minimum essential medium, pH 7.6,
supplemented with 10% newborn bovine serum and
100 µg/mL gentamicin] for virus isolation in cell cul-
ture (except for site 3 at slaughter). From 10 fish,
including the moribund fish, tissue samples were col-
lected in 10% neutral buffered formalin for histo -
pathological examination, and consisted of heart,
pyloric caeca with pancreas, muscle, gill, liver, kidney
and spleen; with the exception of the last samples
from sites 1 and 3 when only heart, pyloric caeca with
pancreas and muscle were collected. Samples were
shipped on ice with overnight delivery or, if neces-
sary, refrigerated overnight prior to overnight ship-
ping to the NVI [Norwegian Veterinary Institute]. All
samples, except for formalin fixed tissues, were stored
at −80°C until analysis was performed (Jansen et al.
2010, p. 725–726).
Explanation:
Specimen handling, transportation, and storage
may affect the sensitivity of some tests (e.g. virus,
bacteria, and parasite isolation) more than others
(e.g. quantitative PCR), but relevant information
should be reported regardless of test type. The
description in the example could have been im -
proved by indicating whether gross lesions, if pres-
ent in heart and muscle, were sampled and how soon
testing was done after storage, as the latter may
affect the probability of virus isolation from infected
tissues. Flow charts are useful to show sampling
schemes, as in Patil et al. (2008), who also included
sampling times in their text description.
Item 6: Describe study design. For field studies,
was data collection planned before the TUE and ref-
erence standard were performed (prospective study)
or after (retrospective study)? For experimental stud-
ies, were archived samples included? Describe
details of storage and retrieval techniques and times.
Example:
Gustafson et al. (2008) described their infectious
salmon anemia (ISA) surveillance program used to
generate data for evaluation of 2 diagnostic tests
(conventional RT-PCR and indirect fluorescent anti-
body, IFAT) as ‘cross-sectional’. In this study, 10 461
samples were collected from 2002 to 2005 from
Atlantic salmon farms in Maine, USA, as part of a
surveillance program and submitted for parallel test-
ing for ISA virus (ISAV) by IFAT and RT-PCR.
Explanation:
Prospective and cross-sectional designs, using
standardized procedures for sample collection, trans-
portation and handling, usually allow for better qual-
ity and consistency of samples with more detailed
descriptive data of populations and animals sampled
than would normally occur in a retrospective study
using repository samples. The example by Gustafson
et al. (2008) meets those criteria as do the examples
in Items 3b and 4b, where the authors used prospec-
tively generated experimental samples for validation
of the TUE. The infection trials described in Items 3b
and 4b were conducted for the purpose of generating
material of known history of pathogen exposure to
facilitate evaluation of test accuracy. In contrast,
Warg et al. (2014b) described the use of historical
experimental infection trials in specific-pathogen-
free Pacific herring Clupea pallasi to generate kid-
ney and spleen samples for comparison of the sensi-
tivity of 2 real-time PCR assays for VHSV genotype
IVa. Storage methods (including preservation tech-
nique, tissue or sample type, temperature, repeated
thaw-freeze samples, to name a few) should be
reported as in Warg et al. (2014b) because deteriora-
tion of samples may lead to false-negative test results
(also see Item 5).
Test methods
Item 7: Describe the reference standard (if used)
and its rationale.
Example:
Histological examination was the standard reference
test [for abalone herpesvirus (AbHV)] … in conjunc-
tion with epidemiological information about refer-
ence populations, and expert advice was used as the
presumptive test to determine the true status of the
samples. [Results of qPCR were compared with results
of histological classification of neural tissues for the
presence or absence of ganglioneuritis.] To minimise
the effects of an imperfect reference standard, other
information, such as epidemiological evidence of
AbHV infection, was taken into consideration during
the present study (e.g. prevalence and mortality were
98
Gardner et al.: Test accuracy reporting standards: STRADAS-aquatic checklist
included in the selection of the sites where abalone
were sampled) (Corbeil et al. 2010, p. 8–9).
Explanation:
Authors should provide a justification for their
choice of reference standard (RS) for the specified
testing purpose based on whether the test is recom-
mended in the OIE Manual of Diagnostic Tests for
Aquatic Animals 2015 (OIE 2015b), test cost, rapidity
of results, laboratory considerations, etc. Ideally the
RS should have published estimates of diagnostic
sensitivity and specificity (see the Supplement for
more discussion of RS). Comparison of a TUE with an
imperfect RS may limit the ability of authors to
demonstrate the superiority of new technology for
detection of infectious diseases (Limmathurotsakul et
al. 2012). For example, virus, parasite, and bacterial
isolation are often used as RS for evaluation of the
accuracy of PCR assays because false-positive isola-
tion results rarely occur. If PCRs have greater diag-
nostic sensitivity (and comparable diagnostic speci-
ficity) to organism isolation, it is never possible to
demonstrate this with traditional statistical approa -
ches because an imperfect RS constrains the esti-
mates of a TUE (e.g. PCR) to be less than 100%. The
use of latent class analysis (LCA) methods (also see
Item 13 and the Supplement) does not require speci-
fication of a RS and can be used to estimate sensitiv-
ity and specificity of all TUE subject to certain
assumptions (Branscum et al. 2005).
Item 8: Describe technical specifications of materi-
als and methods involved, including how and when
measurements were taken, and/or cite references for
TUE and reference standards. Specify quality control
samples for TUE and reference standard and speci-
men/analytical unit size of tested samples.
Example:
During diagnostic validation of the VHSV [viral hem-
orrhagic septicemia] RT-qPCR [reverse transcriptase,
real-time PCR], various quality controls were em -
ployed to monitor reaction efficiencies and ensure sci-
entific integrity. At each stage of the VHSV RT-qPCR
assay (i.e. cDNA synthesis and qPCR) at least one
positive and one negative control was included … For
cDNA synthesis, the positive control consisted of 1 µg
of RNA extracted from Atlantic salmon kidney spiked
with VHSV IVb whereas the negative control was
DEPC [diethyl pyrocarbonate treated] water only (no
RNA). Finally, for the VHSV-qPCR portion of the
assay, a low and high positive control was included
such that one reaction contained VHSV-IVb positive
cDNA at 5 × 106 copies µl−1 (high) and another con-
tained 2.5 × 102 copies µl−1 (low). These reactions
were expected to generate Ct [cycle threshold] values
of 20.8 and 35.9, respectively. Negative qPCR controls
were included with each run … (Garver et al. 2011,
p. 102–103).
Explanation:
Tissue processing and sample preparation methods
must be described in detail because laboratories
often adopt and modify methods to suit their specific
needs, including availability of instruments and
reagents. Depending on the method used, virus yield
from tissue samples may vary greatly, and there
could be substantial variation in sensitivities with
subsequent contamination (Whittington & Steiner
1993, Hick et al. 2010, Rimmer et al. 2012). Likewise,
diagnostic sensitivity of PCR-based assays may be
affected by the choice of PCR reagents (Elliott et al.
2013, Jonstrup et al. 2013). For quality control pur-
poses and to provide unambiguous definitions of pos-
itive and negative test results, both negative and pos-
itive controls should be included in each of the test
runs. To show the needed information in this item, a
description of the quality control samples used in a
real-time RT-PCR validation study is presented in the
example above (Garver et al. 2011) and in Greer &
Collins (2007). Authors should also specify whether
or not internal and/or artificial controls are included
in PCR assays to identify false-negative or false-
 positive test results (Snow et al. 2009, Purcell et al.
2014), as well as the protocol for retesting such
 samples.
Samples collected for the TUE and RS need to be
matched carefully, even if collected at the same time.
Consider the example of nervous necrosis virus
(NNV) infection, where brain and eye are the target
organs for viral replication, and young/small fish are
primarily affected. In subclinical NNV infection, it is
possible for one retina to be positive and the other
negative when evaluated using the RS (Hick et al.
2011). As the brain is small and there are 2 eyes per
fish, authors should report how the sample was col-
lected and divided for comparison of 2 different tests
on tissues, such as PCR and histopathology. It is
important that these specifics are reported because
of potential impacts on test agreement for diseases
where pathogen distribution in tissues may not be
uniform or pathogen load may be low.
Item 9: Describe the outcome measure and ration-
ale for the cutoffs and/or categories of the results of
the TUE and reference standard.
Example:
Samples were considered negative for AbHV
[abalone herpesvirus] when the CT value was >35.8.
Conservatively, samples with a CT value <35.0 were
considered clearly positive. Thus, based on this con-
servative estimate, there is an indeterminate range
(CT 35.0 to 35.8) and samples that yielded CT values
within this range were retested (Corbeil et al. 2010, p.
3–4).
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Explanation:
Choice of a cutoff (threshold) value to designate
test results as positive or negative will affect diagnos-
tic sensitivity and specificity estimates and should
consider test purpose, prevalence of infection, costs
of false-positive or false-negative test results, and
whether the epidemiological unit is the individual
animal or the population. Authors should provide
analytical or epidemiological justifications for their
choices of cutoff values. This might be a simple state-
ment such as ‘mean + 2SD of known negative refer-
ence samples’ or ‘at the manufacturer’s recommen -
ded value’ when referring to an ELISA test kit.
Considerations for PCR are more complex (Caraguel
et al. 2011) and include use of a quantitative standard
to define a positive result on a run-to-run basis (Hick
& Whittington 2010).
In some situations, including the example above, 2
cutoff values might be used to define 3 categories of
test results (positive, inconclusive, or negative) with
the inconclusive category reflecting measurement
uncertainty. Samples in the inconclusive range may
be retested with the same or additional tests depend-
ing on the testing purpose and epidemiological unit
of interest. For example, when the Corbeil et al.
(2010) study was done, there was only a single Taq-
Man PCR based on Open Reading Frame (ORF) 49
but additional tests, TaqMan ORF 66 and ORF 77
PCR, as well as a conventional PCR are now used to
obtain a product to sequence to confirm AbHV infec-
tion. Criteria to assess whether results of retested
samples in the indeterminate range are positive, neg-
ative, or still have an inconclusive result should be
specified in the report. Regardless of the choice of
cutoff value, interpretation criteria for technical re -
plicates, especially for those with discordant re sults,
should be reported as in Purcell et al. (2013) with the
retest result, if appropriate. For clarity, Purcell et al.
(2013) could have reported the number of suspect
samples and the final interpretation of their retest.
Item 10: Describe the name, location, and qualifi-
cations of the laboratory, including the number,
training, and expertise of persons executing the TUE
and reference standard. Specifically indicate if the
laboratory or analyst(s) is involved in any internal or
external assessment program (e.g. proficiency test-
ing).
Example:
Laboratories (‘Labs’) participating in this comparison
had different levels of high-throughput or rRT-PCR
[real-time reverse transcription PCR] testing experi-
ence (Table 2 in Warg et al. 2014a) ranging from
extensive experience (high) to limited experience
(recently trained). In Labs A, D, and E, personnel
were experienced with high-throughput testing and
with conducting rRT-PCR. In Labs B and H, personnel
were experienced with large numbers of samples and
with conventional RT-PCR, but were re cently trained
to perform real-time assays. Labs C and G have dual
roles as both diagnostic and research laboratories
with some experience with both high-throughput
testing and rRT-PCR. Lab F also has dual function
being involved in both re search and diagnostics; in
this laboratory, the technicians were recently trained
in high-throughput testing and to perform real-time
assays (Warg et al. 2014b, p. 18).
Explanation:
Animal health laboratories developing and evalu-
ating test accuracy for OIE-listed diseases are ex -
pected to have a quality management system (QMS)
which addresses technical, managerial, and opera-
tional elements of testing and interpretation of test
results (OIE 2015b). Typically, the QMS will adhere
to standards such as ISO/IEC17025:2005 (www. iso.
org/iso/catalogue_detail.htm?csnumber=39883). Tes -
ting laboratories should report whether they have an
accredited QMS for the laboratory and ISO 17025 or
similar accreditation for the TUE and RS, as appropri-
ate. Reporting of participation in proficiency testing
(see the Supplement) may increase reader confi-
dence in skills of personnel in the laboratory per-
forming tests.
Although difficult to obtain for retrospective stud-
ies where details of RS testing may not be available,
reporting of the number, training, and expertise of
personnel carrying out the TUE and RS allows read-
ers to evaluate the experience of the research or
diagnostic team. Diagnostic accuracy of a TUE and/
or RS may be influenced by personnel factors such as
operator skill in extraction, processing, testing and
reading of samples, especially if the interpretation of
results has a subjective component (e.g. visual exam-
ination of tissue smears). The study in the above
example (Warg et al. 2014b) provides the expertise of
personnel as well as the names of the laboratories,
distinguishing between diagnostic and research lab-
oratories, but lacks specification of the actual accred-
itation. The number of individuals performing tests is
elaborated in another section of their manuscript.
Item 11: Describe whether or not the readers of the
TUE and reference standard were blind (masked) to
the results of the other test and describe any individ-
ual or population-level information available to the
readers.
Example:
Fish [challenged and unchallenged with viral hemor-
rhagic septicemia virus] … were individually bagged
and labeled using a computer-generated random
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number so that the treatment group was unknown to
the laboratory testers (Garver et al. 2011, p. 102).
Explanation:
Although blinding is not necessary in routine diag-
nostic testing, testers participating in diagnostic
accuracy studies should be blinded (masked) to
either the results of the TUE or RS, or both, as appli-
cable to the testing situation. Blinding avoids both
potential bias in the interpretation of test results and
overly optimistic estimates of diagnostic sensitivity
and specificity or the area under the receiver-operat-
ing curve in diagnostic test evaluations. Procedures
for blinding should be described as in the Garver et
al. (2011) example or as in Thébault et al. (2005). If
the joint results of the TUE and RS (positive−positive,
positive−negative, negative−positive, and negative)
are reviewed by testing laboratories and retesting
of samples with discrepant (discordant or non-
 agreeing) results is done using a third test, estimates
of sensitivity and specificity will change and may be
inflated (Hadgu 1999). If this approach is used, sen -
sitivity and specificity based on the original test data
and the retest data should both be reported for
 transparency.
Statistical methods
Item 12: Describe methods for calculating and
 comparing measures of diagnostic accuracy, and the
statistical methods used to quantify uncertainty in
the estimates (e.g. 95% confidence or probability
intervals).
Example:
As neither of the tests used in this study was perfect,
estimation of the sensitivity (Se) and specificity (Sp) of
the RRT-PCR [real-time reverse transcriptase PCR],
VI [virus isolation] and HP [histopathology] was car-
ried out by employing a Bayesian formulation of the
latent class approach … Two models were used: one
assuming conditional independence (CID) between
tests given infection status, and the other allowing full
conditional dependence (COC model) between RRT-
PCR and VI tests given infection status … The CID
and COC models were compared employing the de -
viance information criteria (DIC) … Using Bayesian
posterior probabilities (POPR) calculated as the pro-
portion of MC [Monte-Carlo] samples for which the
hypotheses were true, we tested the one-sided hypo -
theses that the Se and Sp of RRT-PCR were better
than those of VI and HP, respectively (Abayneh et al.
2010, p. 530).
Explanation:
Latent class analysis (LCA), as described in the
example, is recognized as an appropriate method by
OIE when samples of unknown status are used in
diagnostic accuracy studies (OIE 2015a). To our
knowledge, specific guidelines for reporting LCA
studies of diagnostic accuracy have not been pub-
lished, but the underlying assumptions of the model
(e.g. conditional independence, see the Supplement)
should be described and informative priors must be
justified, if used in Bayesian analyses. The latent
class (e.g. infected, infectious, or diseased) should be
explicitly described by the authors because the tar-
get condition for which diagnostic sensitivity and
specificity are being estimated is not implicit in the
analysis. Each analysis should include a description
of criteria to assess model convergence, and a sensi-
tivity analysis should be done comparing informative
versus non-informative priors if the former are used.
For complex models involving covariates and/or a
hierarchical structure, there should be a considera-
tion of model identifiability (see the Supplement and
Jones et al. 2010). Code for analyses should be pro-
vided in an appendix or supplemental file, or refer-
enced. Abayneh et al. (2010) provides a good exam-
ple of reporting many of the needed elements.
When traditional statistical approaches are used
rather than LCA, uncertainty in estimates will de -
pend on the number of positive and negative refer-
ence samples used in a study. These may be limited
and difficult to access depending on the disease situ-
ation in a testing country. For example, ostreid her-
pesvirus-1 (OsHV-1) is endemic in oysters in France,
and it is very difficult to find negative animals, and
these may need to be obtained from countries free of
infection. Hence, diagnostic sensitivity or specificity
estimates in a particular study may be more or less
precise depending on the sample sizes used for esti-
mation of these parameters. Confidence intervals
(CI) and their calculation methods (e.g. exact bino-
mial, normal approximation, score method of Wilson)
should be reported so that readers are fully informed
about the uncertainty in estimates. Corbeil et al.
(2010) provide a thorough description of statistical
methods based on the assumption of a perfect RS,
namely histopathology, including the software used
for the analysis.
Item 13: Describe methods for estimating test
repeatability and reproducibility, if done.
Example:
45 apparently healthy fish were from 3 exposed
cages … 35 apparently healthy fish were from an
infected cage … and 20 dead or moribund fish were
from ISA [infectious salmon anemia] virus clinically
affected cages … From each fish, kidney samples
were collected aseptically in replicates … coded with
a random identification number to blind laboratory
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operators and to avoid test review bias … From each
salmon, duplicate samples were sent on dry ice to the
reference laboratory (lab A) to estimate the repeata-
bility, and single samples were transported on dry ice
to 2 other laboratories (labs B and C) to estimate the
reproducibility … Each of the participating laborato-
ries agreed to test for the presence and absence of
ISAV using the same RT-PCR protocol provided by
the reference laboratory (lab A) … (Caraguel et al.
2009, p. 11).
Explanation:
Description of a reproducibility study should in -
clude the number of replicates used for each factor
investigated (e.g. samples, runs, operators, batches,
laboratories), the range of analytical activity covered
by the selected samples, the nature of the aliquots
(crude, homogenised, extracted, diluted, spiked,
‘plasmid’), whether operator(s) were blinded, any
transformation of test results (ratio, categorization),
and the chosen analytical approach. Details about
the source and analytical activity of the selected
specimen should be provided to assess how well
they covered the assay’s operating range and their
fitness for the intended purpose (OIE 2015a). The
process to aliquot and label the samples should be
reported to assess if replicates were processed using
identical preparation steps to those used for a rou-
tine test sample (e.g. including extraction or dilution
steps). Data from proficiency testing panels but not
ring trials (see the Supplement) might be suitable
for preliminary reproducibility estimates subject to
panel design. Therefore, the panels should be
reported in sufficient detail for readers to judge the
appropriateness of the samples. If the repeatability
and reproducibility of the TUE have been estimated
and reported previously, the relevant citation should
be provided.
Analytical approaches and, therefore, reporting
details differ for qualitative (binary, ordinal) and
quantitative (continuous) test outcomes. Regardless,
the precision of continuous results should be re -
ported using the scale (e.g. transformation, catego-
rization, standardization, or truncation) that will be
used for the intended purpose of the assay, and
appropriate tests of agreement for binary or
ordinal test results should be reported (e.g. kappa
with 95% CI). For a review of methods for estimat-
ing and reporting agreement for continuous test
outcomes, see for example, Barnhart et al. (2007),
Garver et al. (2011), and OIE (2015c). Caraguel et
al. (2011) is a good example of reporting of more
complex modelling methods to investigate the




Item 14: For field studies, report when study was
done, including start and end dates.
Example:
Site 2. Pancreas disease [attributable to salmonid
alphavirus] was diagnosed in cage X in January 2006,
4 months after seawater transfer. The first study sam-
ples (sampling number 0) were collected in February.
The majority of the histopathological-positive fish
showed stage 2 lesions (chronic PD, Table 4) except
one fish in cage Z showing stage 1 lesions (acute PD,
Table 4). At the second sampling (sampling number 1)
nearly 5 months later, only stage 2 histopathological
lesions (chronic PD, Table 4) were found. At the third
sampling (sampling number 2), as well as at slaughter
(sampling number 3), 14 months after the initial sam-
pling, only stage 3 lesions were detected (late/regen-
erative PD, Table 4). The onset of the main mortality
during the outbreak occurred in May, when the sea-
water temperature was 10°C, with a second, smaller
mortality peak also observed in November (Fig. 1b)
(Jansen et al. 2010, p. 730).
Explanation:
Dates of the study and details of recruitment of
populations can be described either in the ‘Mate -
rials and methods’ or ‘Results’ section, depending
on author preference. For longitudinal studies of
aquatic animal populations, reporting of study
dates is important since mortality and morbidity
events are very often seasonal, depending on
rapid fluctuations in water temperatures, light
exposure, salinity, and quality, and may vary with
host factors such as age and size of animals. For
infectious diseases, sampling of clinically affected
animals will typically yield higher estimates of
diagnostic sensitivity for organism detection tests;
hence, reporting of clinical status and longitudinal
mortality data is important. Jansen et al. (2010)
provide detailed descriptions of disease progression
at all 3 sites (including Site 2 as in the example)
and present the longitudinal mortality and sam-
pling data. Their Tables 2 & 3 clearly present
dates of sampling, including sampling numbers
(relative to time of disease diagnosis), results for
the TUEs (including virus isolation), and the
clinical status of tested fish.
Item 15: Report demographic and other biologi-
cally relevant characteristics of the study sample at
the individual level (e.g. age, sex, ploidy, species,
genotype if known, weight, and risk factors) and at
the population level (e.g. production system, water
quality, water temperature, and water salinity).
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Example:
EHNV [epizootic haematopoietic necrosis virus]-in -
fected samples were obtained from experimentally
exposed redfin perch (Perca fluviatilis), Murray−
Darling rainbowfish (Melanotaenia fluviatilis), east-
ern mosquitofish (Gambusia holbrooki), freshwater
catfish (Tandanus tandanus), Macquarie perch (Mac-
quaria australasica) and silver perch (Bidyanus
bidyanus) from trials in which fish were exposed to
102−103 TCID50/ml by bath exposure at 18−24°C [as
described in detail in Becker et al. 2013]. Naturally
infected redfin perch were obtained from different
waterways in New South Wales and the Australian
Capital Territory in Australia. Populations included
both sexes and a variety of ages … The panel of sam-
ples included specimens of both sexes and different
ages and species: redfin perch, river blackfish (Gadop-
sis marmoratus), golden perch (Macquaria ambigua),
trout cod (Maccullochella macquariensis), freshwater
catfish, Macquarie perch and rainbow trout (Jaramillo
et al. 2012, p. 187–188).
Explanation:
In most studies based on cross-sectional sampling
in a single fish species, the reported animal demo-
graphic information is limited (e.g. mean weight of
fish in populations, see McClure et al. 2008). For mul-
tiple fish species, age/size and gender information,
location of sample collection, and number of samples
for each species should be reported. The text descrip-
tion and Table 3 of Jaramillo et al. (2012) provide a
good example of the necessary elements. Their data
were also subclassified by exposure history to EHNV
(deliberately exposed, naturally exposed, probably
ex po sed, and not known to be exposed). Warg et al.
(2014b) is another example, listing in addition other
known viral infections in the sampled fish (see their
Table 1).
Biologically relevant summary information should
be provided for all aquatic animal species because
disease prevalence and intensity of pathogen expo-
sure may depend on age, season, and location. A
basic description is given in the Martenot et al. (2010)
study comparing a new PCR (TUE) for OsHV-1 in
Pacific oysters with a PCR reference test that was
hampered by low analytical sensitivity. The demo-
graphic, temporal, and biological characteristics per-
taining to the samples enable a reader familiar with
OsHV-1 to determine that the samples were from
hosts of a susceptible age from an endemically in -
fected region and were collected at a time when the
disease was active. Therefore, viral load in the
 ‘positive’ samples was probably representative of a
typical diagnostic scenario and thereby supporting
conclusions about relative sensitivity. Had the com -
parison been conducted at a time when infection was
sub-clinical, the RS may have performed poorly due
to low viral load.
Item 16: Report the number of animals and popula-
tions satisfying the inclusion criteria that did or did
not undergo the TUE and/or the reference standard;
describe why animals and populations failed to
receive either test.
Example:
Samples (kidney, spleen or ovarian fluid) were col-
lected from fish at 5 hatcheries for this study and each
facility was coded numerically (1, 2, 3, 4 or 5) … Sam-
ples were either plated immediately or transported on
ice to the University of Idaho within 24 h of collection
where they were then plated for bacterial culture,
except for samples from Hatcheries 4 and 5 where
logistical constraints precluded plating … For sensi-
tivity and specificity estimates for MF-FAT [mem-
brane filtration fluorescent antibody test], ELISA and
nested PCR, analysis was limited to fish that had test
results for all assays resulting in 187 fish sampled
from Hatcheries 1, 2 and 3 [see their Tables 2 & 3]
(Long et al. 2012, p. 409–411).
Explanation:
Studies may be undertaken using populations
of aquatic animals of different infection status
(infected or non-infected) as defined by the RS to
ob tain estimates of diagnostic sensitivity and
specificity. Geographic origin may be used as a
criterion for classification of populations rather
than the RS. In the case of valuable stock (e.g.
barramundi broodstock of high commercial value)
where the RS for detection of nervous necrosis
virus requires destruction of animals, assumptions
may need to be made about infection status in -
stead of applying the RS in the evaluation of new
antibody-detection ELISA tests.
Test results
Item 17: Report time interval between collection of
samples for the TUE and the reference standard and
any interventions administered between for samples
collected ante-mortem.
Example:
… sampling program on 2 farms … was initiated after
one of the farms had experienced a severe outbreak
of VHS which was diagnosed only one week prior to
our first sampling for this study … Samplings were
carried out on the 24th of March, April 30th and May
21st, 2003 … The fish were anesthetised with benzo-
caine and 1−2 ml of blood collected by puncture of the
caudal vein using vacutainers. After blood sampling
fish were euthanized, dissected and pathological
signs were noted (Schyth et al. 2012, p. 594).
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Explanation:
The 11 test accuracy studies in Gardner et al.
(2014) were based on lethal sampling for tissue col-
lection (post-mortem sampling). If samples are only
collected post-mortem and then tested by the TUE
and RS, this item is not relevant. However, in longitu-
dinal studies evaluating tests for infectious diseases,
the TUE may be initially used and then additional
samples collected at post-mortem. The primary rea-
son for reporting this item is the possibility of disease
progression bias if the time interval between the TUE
and the RS is biologically significant.
The importance of the time lag depends on the
pathogenesis of the disease of interest and is, there-
fore, pathogen-specific. For example, in a hypotheti-
cal study of rectal swab culture for Yersinia ruckeri
(enteric redmouth), an interval of weeks or months
between swab collection and post mortem examina-
tion to obtain tissues for histological examination may
not be significant due to the chronic nature of these
infections and the persistent carrier state. In contrast,
a hypothetical validation study of a serum neutraliza-
tion (SN) assay for antibodies against VHS virus
would need to consider stage of infection. In the con-
valescent stage, discordance between virus isolation
results from tissues and SN test results might be ex-
pected because, over time, virus may be cleared from
the host due to the immune response, but antibody
titres may decline at a slower rate. Although not a
true validation study, Schyth et al. (2012) covered this
issue well. Similar concerns would apply to  molluscs
even though antibodies are not present. Attempts are
being made to correlate gene expression changes
and serum protein responses with disease status, and
data suggest that molluscs are able to clear viral in-
fections over periods of weeks to months (Paul-Pont
et al. 2013).
Item 18: Report distribution of severity of disease
or stage of infection (define criteria) and other
relevant diagnoses or treatments in animals in the
study sample.
Example:
A total of 400 farmed Atlantic salmon were collected
from 4 distinct populations with different infection
prevalences representing a range of infection stages
according to clinical and historical information … The
4 study populations included: (i) Pop I (near-zero
prevalence population) with 100 apparently healthy
fish from 2 non-exposed cages (50 fish each) at dis-
tinct non-infected sites but from a region historically
infected; (ii) Pop II (low prevalence population) with
130 apparently healthy fish from 3 ex posed cages (20,
50 and 60 fish, respectively) at distinct sites declared
infected; (iii) Pop III (moderate prevalence popula-
tion) with 70 apparently healthy fish from 2 infected
cages (20 and 50 fish, respectively) after an ISA out-
break at distinct sites; and (iv) Pop IV (high preva-
lence population) with 100 fish including a mixture of
apparently healthy, dead and moribund fish from 4
infected cages (10, 14, 31 and 45 fish, respectively)
during an ISA outbreak at distinct sites (Caraguel et
al. 2012, p. 166).
Explanation:
Diagnostic sensitivity and specificity are population
parameters that can vary according to the distribution
of factors that influence stage of disease and preva-
lence of infection (Greiner & Gardner 2000). Infection
prevalence can also vary with environmental condi-
tions, host species, and pathogen load, but the com-
plex relationship between these factors is poorly doc-
umented for most infectious diseases of animals.
Diagnostic sensitivity is expected to be higher when
a greater quantity of the target analyte such as live
virus is present in individual animals, typically during
the clinical phase of infection compared with the re-
covery phase when animals may be apparently
healthy. If the spectrum of disease severity in the
study population is not representative of the spectrum
of disease in the target population, the study estimates
of diagnostic sensitivity and specificity may be in -
valid. Thus, it is important to report the former to as-
sess a test’s fitness for intended use in a target popula-
tion. In fish aquaculture, the severity scale for clinical
signs is often limited to ‘apparently healthy’, ‘runt’,
‘moribund’, or ‘dead or mortality’ and is used typically
as a proxy for disease stages. For shellfish, the classifi-
cation may only be moribund/dead versus healthy.
The severity of disease in the study population is then
often reported using the proportion of animals in
these clinical categories (Nérette et al. 2008, Caraguel
et al. 2012). Fig. 1 in Jansen et al. (2010) is also a good
example because it combines histopathological find-
ings, pathogen load, serological status and clinical
signs to describe the spectrum of disease stages in the
study population. Caraguel et al. (2009) provide a
novel example of presentation of test results across
multiple populations. Finally, concomitant disease(s)
or interventions, such as vaccination or antibiotic
treatment, in a study population may im pact test ac-
curacy (i.e. more false-positive or false-negative re-
sults) and should also be reported. Ideally, test accu-
racy estimates should be obtained for each set of
relevant environmental and host conditions, but the
cost to get this information might be prohibitive.
Item 19: Report a cross tabulation of the results of
the TUE (including indeterminate and missing
results) by the results of the reference standard. For
continuous results, report the distribution of the test
results by the results of the reference standard.
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Example:
For continuous test results, an interactive dot dia-
gram as shown in our Fig. 1 (Fig. 4 reproduced here
from Corbeil et al. 2010) can be used to illustrate the
best separation (minimal false-negative and false-
positive results) between the positive and negative
groups of a TaqMan PCR for abalone herpesvirus. A
cut-off CT value of 35.8 (horizontal solid line) was
used and histopathology was the reference standard
(0 = negative, 1 = positive).
Explanation:
Presentation of results of the TUE compared with
the RS in 2 × 2 tables, sometimes categorized by pop-
ulation-level exposure status, is common practice in
many test evaluation studies (see for example Cor-
beil et al. 2010, Garver et al. 2011, Jaramillo et al.
2012). However, few authors present analysis of data
in a continuous form (exceptions include True et al.
2009, Corbeil et al. 2010, Purcell et al. 2013). Corbeil
et al. (2010) also presented the receiver operating
characteristic (ROC) curve with its 95% CI for their
TaqMan PCR (see their Fig. 3). Where valid inconclu-
sive results of the TUE occur, these can be presented
in 3 × 2 tables as described in Shinkins et al. (2013).
When more than 2 tests are included in the test
evaluation study, transparent reporting is more chal-
lenging. One solution is to report the frequencies of
the joint test results classified as positive or negative
for all possible combinations of results. In Table 1 of
their paper, Abayneh et al. (2010) show the cross-
 tabulated results of 3 tests (histopathology, real-time
RT-PCR, and virus isolation) in 2 subpopulations of
fish. This format allows collapsing of data across tests
and populations, if necessary, and can also be modi-
fied to account for missing results due to insufficient
or poor quality samples or selective testing to reduce
study costs. For example, if virus isolation were
attempted on a random sample of 83 (50%) rather
than all 166 samples in the Abayneh et al. (2010)
study, 8 additional data rows would be needed to
account for the failure to test all samples. This should
be reported as described in Item 16.
Another solution is to create a comprehensive flow
chart of sample numbers, sampling protocols, and
results of the TUE versus RS to report transparently
not only comparative results between assays but
also possible time-varying (see Item 17), sample-
 dependent (see Item 16), and inadequate RS effects
that may present a potential bias to interpretation of
TUE results. For example, consider a modified ver-
sion of the sampling method flow chart (see Item 7)
from Patil et al. (2008) (Fig. 2). Here the lag time
between the TUEs and reference standard testing for
white spot syndrome virus (WSSV) detection, miss-
ing samples (for 2-step PCR), and different tissue
sampling may be biases (see also Item 22) the authors
could have addressed when discussing and inter-
preting the benefits of immunoblot testing on pleo-
pod samples compared with other testing and sam-
pling method combinations.
Item 20: Report any adverse events from perform-
ing the TUE or the reference standard for samples
collected ante-mortem.
Explanation:
Similar to Item 17, if samples are only collected and
tested post-mortem, this item is not relevant. However,
if blood samples, gill snips, mucus scrapings, fin clips
or tissue biopsies are taken for ante-mortem diagnosis,
and especially if repeated over time as in an experi-
mental challenge study, there may be harms (e.g.
mortality, morbidity, and reduced growth) attributable
to sampling and handling. In field settings in finfish,
environmental (e.g. high temperature, low dissolved
oxygen) and physiological stressors (e.g. spawning in
adult migrating salmon) may increase the risk of ad-
verse outcomes. The negative effects of collection of
samples for diagnostic testing should be reported,
even if individual fish are of low financial value.
Table 1 of Elliott et al. (2015) showed mortality associ-
ated with 5 candidate non-lethal sampling methods
for Renibacterium salmoninarum in Chinook salmon
compared with anaesthesia only and no treatment,
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Fig. 1. Interactive dot diagram showing the distribution of
TaqMan PCR results for abalone herpes virus compared
with histopathology as the reference standard (0 = negative,
1 = positive). Horizontal line at a cycle threshold (CT) of 35.8
was the cutoff for test interpretation. Reproduced from Cor-
beil et al. (2010; their Fig. 4) 
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thereby allowing readers to assess negative conse-
quences of the non-lethal sampling.
Negative effects of repeated sample collection may
be site-specific, systemic, or both and could impact
test validation under 2 conditions. The first instance is
if there was a delay between collection for the TUE
and the RS as described in Item 17. However, ne -
gative consequences are important only if animals are
lost from the study or if the consequences differentially
affect either the TUE or RS. For example, a single
blood collection from the caudal vein in finfish can
lead to spinal cord damage with locomotor dysfunc-
tion. These detrimental effects may directly impact
the TUE if longitudinal sampling approaches are used
in individuals. Second, collection of a sample for Test
A may damage tissues to be evaluated using Test B.
Comparisons of skin scrapings with histo pathology
would be an obvious example, which would generally
force the use of different sites on the host for each test.
Estimates
Item 21: Report estimates of diagnostic accuracy
and measures of statistical uncertainty (e.g. 95%
confidence intervals).
Example:
The highest diagnostic sensitivity and specificity were
96.7 (95% CI: 82.7 to 99.4) and 99.7 (95% CI: 99.3 to
99.9), respectively, at a threshold cycle (CT) value of
35.8 … [and] The AUC [area under the curve] of the
AbHV [abalone herpesvirus] TaqMan assay was
0.998. Hence, this assay can be considered a highly
accurate test (Corbeil et al. 2010, p. 1 & 7).
Explanation:
Reporting of 95% confidence intervals is standard
practice in the majority of diagnostic accuracy stud-
ies in aquatic animals when reference samples are
used or results of a TUE are compared with a RS that
is assumed to be perfect. If a LCA analysis in a
Bayesian framework is used for parameter estimation
using samples from populations of unknown status,
the mean (or median) sensitivity and specificity
should be reported with 95% probability (credibility)
intervals. These are typically derived from the output
of software programs such as WinBUGS (Lunn et al.
2000) that allow ready implementation of Bayesian
methods. Table 2 in Abayneh at al. (2010) provides
a good example of reporting of these methods.
In another well-reported study, Thébault et al. (2005)
compared use of TAGS (an internet-based program
to implement LCA with maximum likelihood
 methods, available at https://rpouillot.shinyapps.io/
TAGS/), Bayesian LCA models, and traditional RS
analysis to estimate diagnostic sensitivity and speci-
ficity for Marteilia refringens in oysters. The authors
reported estimates by all 3 methods in Table 6 of
their paper and discussed the comparative findings
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Fig. 2. Flow chart modified from Patil et al. (2008; their Fig. 1) to include results of tests under evaluation (TUEs) relative to the
reference standard (see Item 19). TP: true positive (i.e. TUE positive and reference standard positive); FP: false positive (i.e. 
TUE negative and reference standard positive); FN: false negative; TN: true negative
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and strengths and weaknesses of the different statis-
tical approaches.
Item 22: Report how indeterminate results, missing
responses, and outlier values of the TUE and the ref-
erence standard were handled.
Example:
Electrophoresis gels were examined carefully, and
PCR was repeated on samples where a very weak
intensity band at the expected size was observed ini-
tially. If the second PCR result was positive again, the
final result was positive; if not, it became negative
(Caraguel et al. 2009, p. 12).
Explanation:
Inconclusive test results (see definitions in the
Supplement and Shinkins et al. 2013) may be
caused by sample (e.g. poor quality or low quantity),
animal (e.g. concomitant disorder or therapy), or
analytical factors (e.g. measurement uncertainty
near the cutoff). Historically, many terms have been
used somewhat interchangeably for inconclusive
results including uninterpretable, intermediate,
indeterminate, uninformative, suspicious, and sus-
pect. Shinkins et al. (2013) have proposed that
inconclusive results should be categorized as either
invalid or valid. Invalid results include missing (e.g.
insufficient or poor quality sample) and uninter-
pretable results (e.g. overgrowth of a culture by a
non-target organism). These 2 types of results can
be treated identically, and the test can be repeated
if the event occurs independently of the presence or
absence of disease. The frequency of these results
should be reported by the RS, if used, and possible
effects on the diagnostic sensitivity and specificity
of TUE should be explored, and their practical
implications (e.g. cost of retesting and diagnostic
utility) should also be discussed.
The frequency of both types of inconclusive results
is rarely reported in aquaculture studies. If common,
these results will impact the usefulness of the assay
in routine use. Therefore, it is important to report the
frequency of inconclusive test results and how they
were managed. Inconclusive samples may be re -
tested using the same test or a confirmatory test. Any
additional testing is now part of the overall detection
protocol, and the details of the interpretation of each
test result combination should be reported. The inter-
pretation of several test results from the same sample
can result in very different overall values for diag-
nostic sensitivity and specificity. For instance, addi-
tion of a confirmatory test to the TUE, interpreted in
series, is likely to decrease its diagnostic sensitivity
and increase its diagnostic specificity (assuming con-
ditional independence between the 2 tests) (Gardner
et al. 2000). With real-time PCR technology, it is rou-
tine to run duplicates of samples, and contradictory
results (e.g. one positive and one negative) often
occur when CT values are close to the cutoff. Inter-
pretation or retesting of contradictory samples should
be detailed in the report. For example, in one of our
laboratories the original raw material is used, is
extracted in duplicate, and all 4 nucleic acid samples
are tested.
Item 23: Report estimates of variability of diagnos-
tic accuracy between relevant subpopulations, oper-
ators/readers, host factors, agent factors, or testing
sites, if done. For challenge studies, report temporal
variation in sensitivity estimates compared with days
post-challenge.
Example:
Table 3 of Nérette et al. (2008) reported specificity
estimates and 95% CI of a PCR for ISAV in 4 popula-
tions (apparently healthy fish in a non-outbreak cage
on the same infected site or nearest neighboring site,
apparently healthy fish in a sick (outbreak) cage;
moribund fish in an outbreak cage; and apparently
healthy fish from a population assumed to be free of
ISA). Tables 5 & 7 of Hyatt et al. (2007) report the
diagnostic window or capability to detect infection
for the different tests evaluated. For example, they
explain in one such case: 
The TaqMan assay following the wash protocol was
the most efficient assay, as this technique detected
infection in >50% of the infected animals as early as
7 d p.i. More than 25, 50 and 75% of infected animals
were detected at Days 7, 14 and 21, respectively
(Table 5). Following the wash protocol, this test
achieved the highest sensitivity, i.e. 97%, at Day 35
p.i. in this experiment (Table 3). (Hyatt et al. 2007,
p. 183)
Explanation:
As described in Item 18, test accuracy can vary
with operational (e.g. technician, reader and labora-
tory) and biological factors (e.g. strain or genotype,
disease stage, host profile, and population profile).
When investigated, covariate-specific estimates
should be reported with 95% CI. These estimates
provide a better understanding of the accuracy of the
test under variable conditions and potentially facili-
tate extrapolation of study findings to an external
population or different testing purpose. For instance,
if a test was evaluated for screening purposes using a
mixed population with apparently healthy and mori-
bund fish, one could use the diagnostic sensitivity
and specificity estimates of moribund fish only when
testing to confirm clinically suspect (moribund)
cases. Other study examples that provide covariate-
specific estimates for various clinical categories
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include Jansen et al. (2010) and, for separate agent
genotypes, Gustafson et al. (2008).
Item 24: Report estimates of test repeatability and
reproducibility, if done.
Example:
Overall repeatability revealed slightly lower Pa [ob -
served proportion of agreement] than overall repro-
ducibility (0.81 [95% CI 0.75−0.86] and 0.82 [95% CI
0.76− 0.88], respectively), although the overlap of CIs
provided little evidence of significant difference
(Table 2). Tests from pairwise comparisons involving
lab C showed serious disagreement with the 2 other
laboratories regardless of the sample type (significant
McNemar’s test). Estimates of k [kappa statistic]
ranged from 0.57 to 0.73 and supported Pa results
(Table 2) (Caraguel et al. 2009, p. 14).
Explanation:
Estimates of repeatability and reproducibility (see
Supplement definitions) should be reported with
95% CI. For continuous outcomes, imprecision is
most relevant for test values near the cutoff point and
should be reported. The precision of continuous tests
can be illustrated graphically across analyte concen-
tration using a boxplot, concordance plot or Bland-
and-Altman (see, for example, Corbeil et al. 2010,
Garver et al. 2011, and Jonstrup et al. 2013). For
binary outcome tests, a novel graphical approach
using phylogenetic tree representation was devel-
oped to represent clustering (agreement) among test
replicates (Caraguel et al. 2009). Changes in repeata-
bility and reproducibility according to relevant sam-
ple factors (e.g. tissue homogenisation in Caraguel et
al. 2009), host factors (e.g. degree of infection in
Caraguel et al. 2011), operator/readers (e.g. level of
experience), laboratory factors (e.g. different instru-
ments used in different laboratories; see Hyatt et al.
2007), agent factors (e.g. strain), population factors
(e.g. prevalence in Caraguel et al. 2011), or testing
location should be reported if investigated.
Discussion
Item 25: Discuss the fitness for the stated purpose
and the utility of the TUE in various settings (clinical,
research, surveillance, etc.) in the context of the cur-
rently available tests. For challenge studies, critically
evaluate the relevance of the experimental challenge
study to naturally occurring infection/disease and ex-
plain why the latter source of samples was not used.
Example:
The IQ Plus™ WSSV Kit with POCKIT system, a diag-
nosis assay allowing pond-side detection of WSSV,
would help shrimp farmers and local offices to respond
to disease outbreaks in an efficient and timely man-
ner. For field users, equipment and accessories re -
quired to run the assay (POCKIT™, a mini-centrifuge,
pipettes, and pipette tips) are combined into a mobile
package (POCKIT™ Xpress) to allow great mobility of
the system. Compared to shipping samples to central-
ized laboratories for WSSV diagnosis, the POCKIT™
assay could significantly lower the costs and shorten
the sampling-to-result turn-around time from days to
a few hours … Testing by IQ PlusTM WSSV Kit with
POCKIT system costs around US$10 per sample,
which is relatively inexpensive in comparison to the
costs of sending samples to be diagnosed by standard
and/or real-time PCR assays at a laboratory, which
could cost more than US$50 for each target pathogen
plus fees for handling and shipping (Tsai et al. 2014,
p. 7).
Explanation:
Interpretation is a final and critical step in diagnos-
tic accuracy studies in the context of fitness for pur-
pose. Ultimately, decisions about test selection for
disease or epidemiologic investigations, or how to
interpret results for trade, are the end-use. In their
abstract and discussion, authors should provide clear
statements about the fit and constraints of their find-
ings in the context of target populations and other
available tests for a designated purpose. Considera-
tions such as test cost, laboratory capacity, rapidity of
results, and technical complexity should also be dis-
cussed in this context as they affect test choice. Can-
did discussions of situations in which test results can
or cannot be reliably applied (e.g. populations and
decision contexts) will facilitate informed decisions
by readers about potential end-use.
Hyatt et al. (2007) provide a good example of this in
their study of assessing 3 assays and various sam-
pling techniques for B. dendrobatidis in amphibians.
The authors directly mention the term ‘fitness of pur-
pose’ in the first section of their study’s discussion,
then provide details for each aspect, mentioning
which sampling methods would be better in experi-
mental versus field applications. Their Table 13 lists
their recommendations (based on their comparative
analyses) for an international standard for the OIE for
sampling (field, lab, pools, storage) and for using
real-time TaqMan PCR for B. dendrobatidis in
amphibians and how to interpret the results.
Potential adverse effects of tests with imperfect
specificity should be explicitly described especially
if aquatic animal trade is affected. Tsai et al. (2014,
p. 7) stated that: 
WSSV-like sequences, occupying around 20% of the
P. monodon genome, have been found to be present
throughout the shrimp genome in a genome sequen-
cing study … This is a cause for concern that the prob-
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ability of false-positive diagnosis of white spot syn-
drome disease is likely to rise from cross reactivity of
PCR primer and probe with target homologs within
shrimp genome.
If experimental challenge studies are used for esti-
mation of diagnostic sensitivity, authors should dis-
cuss how their experiment mimics natural exposure
and disease progression. For example, a design
based on cohabitation and waterborne exposure
would be appropriate for abalone viral ganglioneuri-
tis because disease progression to mortality is only a
few days, and hence, it is difficult to harvest live wild
abalone at different stages of infection to investigate
the pathogenicity of the etiological agent. Therefore,
experimental infection of healthy animals is neces-
sary to study the interaction(s) between host and
pathogen (S. Corbeil and K. A. Garver pers. obs.) as
well as temporal changes in pathogen distribution in
tissues and associated histopathological changes.
The Jonstrup et al. (2013) study described the use of
samples from fish after an acute challenge experi-
ment to validate a test for surveillance purposes. In
that study, quantification of the viral pathogen by
both the TUE and the RS was used to demonstrate
the presence of a range of viral quantities, including
samples close to the TUE’s limit of detection. There-
fore, the necessary positive samples for validation
were obtained for a scenario where attainment of
field samples for the combination of species and
pathogen was not possible because, in a surveillance
to demonstrate freedom setting, negative samples
are all that are available locally.
CONCLUSIONS
Design and reporting quality are interrelated
aspects of test accuracy studies, but evaluation of
studies in public health suggests that even well-
designed studies may fail to be reported in sufficient
detail to allow end-users to critically assess utility of
the TUE. In a prior review of reporting quality of the
published finfish papers (Gardner et al. 2014), defi-
ciencies were identified in many items. The goal of
the present study was to develop a checklist tool to
improve reporting of test accuracy studies in cultured
and wild aquatic animals in the context of fitness for
purpose. To support their use, we provide real exam-
ples that show most, if not all, of the necessary ele-
ments for each of the 25 checklist items. We did not
prioritize items because we believe that all are im -
portant and interrelated and therefore require ex -
plicit description in manuscripts.
Funding for diagnostic validation studies for
aquatic pathogens is very limited in most countries.
Hence, simple changes in reporting will benefit the
aquatic animal health community and help to ensure
that findings are useful for decision support in  real-
world applications. Reporting guidelines offer addi-
tional benefits to authors, reviewers and journal
 editors by providing a structured and consistent ap -
proach for manuscript preparation and peer-review.
As an initial step to improve reporting  quality, we
recommend that authors follow the STRADAS-
aquatic guidelines and submit the checklist as sup-
plementary materials with their papers noting the
page and line number where each item is addressed
in a manuscript. Finally, we reiterate that the guide-
lines and checklist are generic and are applicable to
all aquatic animals. The guidelines should also help
researchers make more informed decisions about
design given knowledge of key information to be
reported.
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